Switzerland· 66217001
Efavirenz-Emtricitabin-Tenofovir-Mepha
A emtricitabine, tenofovir disoproxil and efavirenz product containing efavirenzum, emtricitabinum, tenofovirum disoproxilum, registered in Switzerland and dispensed under Swissmedic category A, on the national reimbursement list. The same ATC class is registered in 13 of our 19 countries.
Checked against BAG Spezialitätenliste (Switzerland) on
Informational only — not a medical device.
Where it is registered
Emtricitabine, tenofovir disoproxil and efavirenz is registered in 13 of 19 countries.
Countries holding a registration under ATC J05AR06 (emtricitabine, tenofovir disoproxil and efavirenz), each read from that country’s own register.
- This record: Switzerland, from BAG Spezialitätenliste (Switzerland)
- 8 of them publish a price we can compare per daily dose
Emtricitabine, tenofovir disoproxil and efavirenz · ATC J05AR06
13 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
BAG Spezialitätenliste (Switzerland)- Active substance
- efavirenzum, emtricitabinum, tenofovirum disoproxilum
- Manufacturer
- —
- Country
- Switzerland (CH)
- ATC code
- J05AR06
- ATC class
- Emtricitabine, tenofovir disoproxil and efavirenz
- Swissmedic category
- A
- Reimbursed
- Yes
- Source register
- BAG Spezialitätenliste (Switzerland)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- gtin768066217001830 StkCHF 588.5
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
4 interactions on record for emtricitabine, tenofovir disoproxil and efavirenz.
Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Emtricitabine, tenofovir disoproxil and efavirenz · interactions on record
4 records
4 more interactions with mechanism and management, from a commercially licensed source.
Sign in to checkSame medicine, other countries
Emtricitabine, tenofovir disoproxil and efavirenz in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandAtriplaOrifarm Oy
- GermanyEfavemtenTad Pharma Gmbh
- FranceATRIPLA 600 mg/200 mg/245 mg, comprimé pelliculéGILEAD SCIENCES IRELAND UC (IRLANDE)
- CzechiaEFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL KRKAKrka, d.d., Novo mesto, Novo mesto
- United Statesefavirenz, emtricitabine and tenofovir disoproxil fumarateCipla USA Inc.
- United KingdomAtripla 600mg/200mg/245mg tabletsGilead Sciences Ltd
- CanadaAPO-EFAVIRENZ-EMTRICITABINE-TENOFOVIRAPOTEX INC
- SwedenEfavirenz/Emtricitabine/Tenofovir disoproxil Glenmark 600 mg/200 mg/245 mg Filmdragerad tablettGlenmark Arzneimittel GmbH
Authorised across Europe · EMA
The same active substance is authorised in 19 EEA countries. Names it is sold under:
- Austria · Efavirenz/Emtricitabin/Tenofovirdisoproxil Ratiopharm
- Germany · Efavemten, Efavirenz/Emtricitabin/Tenofovirdisoproxil Aliud
- Denmark · Efavirenz/Emtricitabine/Tenofovir Disoproxil Glenmark, Efavirenz/Emtricitabine/Tenofovir Disoproxil Teva
- Estonia · Efavirenz/Emtricitabine/Tenofovir Disoproxil Zentiva K.S., Padviram
- Spain · Efavirenz/Emtricitabina/Tenofovir Disoproxilo Aurovitas, Efavirenz/Emtricitabina/Tenofovir Disoproxilo Dr. Reddys
- Finland · Fatrino
- France · Efavirenz/Emtricitabine/Tenofovir Disoproxil Arrow, Efavirenz/Emtricitabine/Tenofovir Disoproxil Bgr
- United Kingdom (Northern Ireland) · Efavirenz/Emtricitabine/Tenofovir Disoproxil Glenmark Pharmaceuticals Europe, Efavirenz/Emtricitabine/Tenofovir Disoproxil Macleods
- Croatia · Efavirenz/Emtricitabin/Tenofovirdizoproksil Stada
- Ireland · Efavirenz/Emtricitabine/Tenofovir Disoproxil Teva
- Iceland · Efavirenz/Emtricitabine/Tenofovir Disoproxil Krka, Efavirenz/Emtricitabine/Tenofovir Disoproxil Mylan
- Italy · Efavirenz E Emtricitabina E Tenofovir Disoproxil Aurobindo, Efavirenz/Emtricitabina/Tenofovir Disoproxil Zentiva K.S.
- Liechtenstein · Efavirenz/Emtricitabine/Tenofovir Disoproxil Mylan 600 Mg/200 Mg/245 Mg Film-Coated Tablets Mylan
- Netherlands · Efavirenz/ Emtricitabine/ Tenofovir Disoproxyl Fumarate Aurobindo, Efavirenz/Emtricitabine/Tenofovir Disoproxil Glenmark
- Norway · Efavirenz/Emtricitabine/Tenofovir Disoproxil Krka, Efavirenz/Emtricitabine/Tenofovir Disoproxil Mylan
- Poland · Efavirenz + Emtricitabine + Tenofovir Disoproxil Aurovitas
- Portugal · Efavirenz + Emtricitabina + Tenofovir Generis, Efavirenz + Emtricitabina + Tenofovir Teva
- Romania · Efavirenz/Emtricitabină/Tenofovir Disoproxil Zentiva K.S.
- Sweden · Efavirenz/Emtricitabine/Tenofovir Disoproxil Glenmark, Efavirenz/Emtricitabine/Tenofovir Disoproxil Teva
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of BAG Spezialitätenliste (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c61ab488-b838-4c1f-b947-cabfcae15c81 GET /v1/drugs/c61ab488-b838-4c1f-b947-cabfcae15c81?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"unit": null,
"strength": "efavirenzum 600 mg + emtricitabinum 200 mg + tenofovirum disoproxilum 245 mg",
"valid_from": "2021-04-01",
"limitations": null,
"galenic_form": "Lactab 600mg/200mg/245mg",
"therapeutic_area": null,
"sl_inclusion_date": "2021-04-01",
"self_retention_pct": 10
}See everything about emtricitabine, tenofovir disoproxil and efavirenz.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.